BOTTA, FRANCESCA
BOTTA, FRANCESCA
DIPARTIMENTO DI FISICA (attivo dal 01/07/1979 al 26/04/2012)
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
2023 S. Mazzara, L. Travaini, F. Botta, C. Granata, G. Motta, F. Melle, S. Fiori, V. Tabanelli, A. Vanazzi, S. Ramadan, T. Radice, S. Raimondi, G. Lo Presti, M.E. Ferrari, B.A. Jereczek-Fossa, C. Tarella, F. Ceci, S. Pileri, E. Derenzini
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma]
2023 L. Lavinia Travaini, F. Botta, E. Derenzini, G. Lo Presti, M. Esmeralda Ferrari, L. Simona Air(`(o)) Farulla, T. Radice, S. Mazzara, C. Tarella, S. Pileri, S. Raimondi, F. Ceci
Personalized Dosimetry in Targeted Radiation Therapy: A Look to Methods, Tools and Critical Aspects
2022 R. Danieli, A. Milano, S. Gallo, I. Veronese, A. Lascialfari, L. Indovina, F. Botta, M. Ferrari, A. Cicchetti, D. Raspanti, M. Cremonesi
Recent radiomics advancements in breast cancer: Lessons and pitfalls for the next future
2021 F. Pesapane, A. Rotili, G.M. Agazzi, F. Botta, S. Raimondi, S. Penco, V. Dominelli, M. Cremonesi, B.A. Jereczek-Fossa, G. Carrafiello, E. Cassano
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)
2021 S.G. Gugliandolo, M. Pepa, L.J. Isaksson, G. Marvaso, S. Raimondi, F. Botta, S. Gandini, D. Ciardo, S. Volpe, G. Riva, D.P. Rojas, D. Zerini, P. Pricolo, S. Alessi, G. Petralia, P.E. Summers, F.A. Mistretta, S. Luzzago, F. Cattani, O. De Cobelli, E. Cassano, M. Cremonesi, M. Bellomi, R. Orecchia, B.A. Jereczek-Fossa
The Challenge of Choosing the Best Classification Method in Radiomic Analyses: Recommendations and Applications to Lung Cancer CT Images
2021 F. Corso, G. Tini, G. Lo Presti, N. Garau, S.P. De Angelis, F. Bellerba, L. Rinaldi, F. Botta, S. Rizzo, D. Origgi, C. Paganelli, M. Cremonesi, C. Rampinelli, M. Bellomi, L. Mazzarella, P.G. Pelicci, S. Gandini, S. Raimondi
Association of a CT-Based Clinical and Radiomics Score of Non-Small Cell Lung Cancer (NSCLC) with Lymph Node Status and Overall Survival
2020 F. Botta, S. Raimondi, L. Rinaldi, F. Bellerba, F. Corso, V. Bagnardi, D. Origgi, R. Minelli, M.G. Pitoni, F. Petrella, L. Spaggiari, A.G. Morganti, F. Del Grande, M. Bellomi, S.M.R. Rizzo
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma
2020 C. Giannitto, G. Marvaso, F. Botta, S. Raimondi, D. Alterio, D. Ciardo, S. Volpe, F. de Piano, E. Ancona, M. Tagliabue, D. Origgi, S. Chiocca, F.A. Maffini, M. Ansarin, V. Bagnardi, F. Cattani, F. Nole, L. Preda, R. Orecchia, E. Cassano, M. Cremonesi, A. Starzynska, M. Bellomi, B.A. Jereczek-Fossa
High precision radiotherapy including intensitymodulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: A retrospective monoinstitutional study
2019 A. Vavassori, G. Riva, R. Spoto, R. Lazzari, C. Fodor, S. Dicuonzo, C.M. Francia, M. Augugliaro, G. Facondo, R. Cambria, S. Comi, F. Cattani, F. Botta, V. Bagnardi, S. Rizzo, N. Colombo, R. Orecchia, B.A. Jereczek-Fossa
Role of interim F-18-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy : a systematic review
2017 M. Cremonesi, L. Gilardi, M.E. Ferrari, G. Piperno, L.L. Travaini, R. Timmerman, F. Botta, G. Baroni, C.M. Grana, S. Ronchi, D. Ciardo, B.A. Jereczek-Fossa, C. Garibaldi, R. Orecchia
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective
2014 M. Cremonesi, C. Chiesa, L. Strigari, M. Ferrari, F. Botta, F. Guerriero, C. De Cicco, G. Bonomo, F. Orsi, L. Bodei, C.M. Grana, R. Orecchia
Planning combined treatments of external beam radiation therapy and molecular radiotherapy
2014 M. Cremonesi, M. Ferrari, F. Botta, F. Guerriero, C. Garibaldi, L. Bodei, C. De Cicco, C.M. Grana, G. Pedroli, R. Orecchia
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy
2012 M.E. Ferrari, M. Cremonesi, A. Di Dia, F. Botta, C. De Cicco, A. Sarnelli, P. Pedicini, M. Calabrese, R. Orecchia, G. Pedroli, G. Paganelli
Correction: modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
2012 P. Pedicini, R. Caivano, B.A. Jereczek-Fossa, L. Strigari, B. Vischioni, D. Alterio, M. Cremonesi, F. Botta, A. Nappi, G. Improta, G. Storto, A. Fiorentino, M. Benassi, R. Orecchia, V. Fusco